| Lactose (India) Ltd | 147 Cr. | 116 | 235/84.3 | 32.4 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.38 Cr. | 1.77 | 4.33/1.76 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,222 Cr. | 389 | 479/192 | 87.4 | 24.3 | 0.17 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 33.8 Cr. | 45.5 | 92.2/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 48.2 Cr. | 32.9 | 33.0/17.0 | 115 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 56.4 Cr. | 74.8 | 121/69.7 | 15.2 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 55,252 Cr. | 1,957 | 2,286/1,275 | 22.0 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 305 Cr. | 12.6 | 19.0/10.8 | 18.3 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 6.90 Cr. | 11.7 | 18.0/9.25 | 86.2 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 767 Cr. | 1,625 | 1,999/635 | 26.6 | 334 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 94.8 Cr. | 19.0 | 32.0/17.0 | 25.9 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 1,030 Cr. | 350 | 449/219 | 9.19 | 133 | 0.71 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 4.35 Cr. | 20.8 | 39.0/20.8 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 8.24 Cr. | 3.31 | 8.45/2.11 | 4.68 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 449 Cr. | 462 | 499/211 | 67.8 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,240 Cr. | 976 | 1,565/969 | 38.4 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 53.2 Cr. | 0.26 | 1.12/0.25 | 3.50 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 35.5 Cr. | 13.5 | 26.3/7.11 | 17.3 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 10.0 Cr. | 9.90 | 17.2/9.00 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 162 Cr. | 455 | 859/431 | 9.20 | 596 | 0.33 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 82.3 Cr. | 82.3 | 92.5/26.1 | 155 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 14,047 Cr. | 1,344 | 2,452/1,315 | 43.7 | 174 | 0.80 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 23.8 Cr. | 52.0 | 88.7/36.1 | 51.7 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 12.2 Cr. | 4.90 | 7.66/2.97 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 16.2 Cr. | 108 | 152/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 57.5 Cr. | 105 | 114/9.41 | 39.7 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 34.0 Cr. | 45.0 | 80.0/33.0 | 54.8 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.45 Cr. | 21.5 | 26.0/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 9,091 Cr. | 524 | 1,028/512 | 25.8 | 72.4 | 0.23 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 81.3 Cr. | 18.8 | 35.9/18.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.6 Cr. | 23.0 | 43.7/17.4 | 50.7 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 88,465 Cr. | 2,142 | 3,055/2,090 | 53.1 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 235 Cr. | 408 | 524/241 | 24.1 | 123 | 1.10 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 52.4 Cr. | 36.5 | 62.6/26.7 | 81.8 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 70,233 Cr. | 1,209 | 1,365/994 | 20.5 | 603 | 0.33 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 154 Cr. | 247 | 303/159 | 147 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 775 Cr. | 77.4 | 123/74.0 | 20.0 | 32.6 | 1.94 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 36.6 Cr. | 28.0 | 47.0/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 13,366 Cr. | 1,631 | 1,902/919 | 59.7 | 173 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 3.96 Cr. | 0.60 | 1.38/0.51 | 99.0 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 209 Cr. | 27.3 | 61.5/26.0 | 13.4 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 4.90 Cr. | 8.37 | 22.2/7.60 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 138 Cr. | 5.85 | 6.57/2.82 | 320 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 59,390 Cr. | 27,980 | 37,000/25,260 | 39.4 | 1,888 | 1.70 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,585 Cr. | 728 | 972/550 | 27.5 | 226 | 0.69 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 193 Cr. | 66.3 | 100/31.3 | 53.8 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,839 Cr. | 1,567 | 1,740/749 | | 103 | 0.06 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 22,415 Cr. | 1,380 | 1,870/1,110 | 409 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 790 Cr. | 226 | 330/154 | 18.4 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 223 Cr. | 26.6 | 29.4/26.5 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 996 Cr. | 747 | 840/270 | 15.7 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,180 Cr. | 452 | 791/432 | 21.8 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,467 Cr. | 1,038 | 1,547/991 | 20.8 | 768 | 0.96 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,27,299 Cr. | 3,760 | 3,882/2,886 | 58.8 | 250 | 0.85 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 919 Cr. | 99.8 | 284/98.0 | | 41.3 | 0.50 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,351 Cr. | 14.4 | 23.5/14.1 | 21.5 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 20,282 Cr. | 530 | 1,328/518 | 59.0 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,802 Cr. | 167 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,18,387 Cr. | 1,746 | 1,910/1,547 | 36.2 | 324 | 0.92 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,546 Cr. | 573 | 734/441 | 397 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,832 Cr. | 304 | 335/175 | 34.9 | 81.2 | 0.13 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,264 Cr. | 321 | 502/265 | 40.5 | 125 | 0.16 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 5,319 Cr. | 209 | 260/111 | 123 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,383 Cr. | 4,076 | 6,718/4,068 | 25.4 | 340 | 2.87 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,894 Cr. | 2,341 | 2,725/1,772 | 34.9 | 335 | 0.85 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,387 Cr. | 5,650 | 6,739/4,904 | 30.6 | 373 | 2.21 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 175 Cr. | 49.7 | 85.0/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 23,377 Cr. | 5,101 | 5,993/3,701 | 33.1 | 841 | 0.69 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 129 Cr. | 105 | 220/81.0 | 13.4 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,146 Cr. | 346 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,985 Cr. | 786 | 1,998/604 | 76.3 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 20,281 Cr. | 15,799 | 19,748/10,060 | 104 | 1,263 | 0.08 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 474 Cr. | 21.1 | 44.9/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 16,382 Cr. | 915 | 1,490/660 | 10.6 | 483 | 0.66 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,115 Cr. | 38.7 | 84.6/38.4 | 28.0 | 21.8 | 0.52 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,223 Cr. | 182 | 324/162 | 23.4 | 59.3 | 0.44 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 38.2 Cr. | 24.3 | 130/23.6 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 266 Cr. | 74.4 | 167/72.2 | 130 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 96,798 Cr. | 2,119 | 2,403/1,774 | 22.4 | 430 | 0.57 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 952 Cr. | 476 | 910/464 | 11.9 | 357 | 0.38 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 54,866 Cr. | 1,016 | 1,040/501 | 80.4 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,037 Cr. | 999 | 1,235/596 | 21.1 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 146 Cr. | 68.1 | 114/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 620 Cr. | 128 | 227/123 | 35.2 | 104 | 2.34 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 589 Cr. | 337 | 500/265 | 21.4 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 16,779 Cr. | 1,054 | 1,250/802 | 33.8 | 414 | 0.47 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 28,029 Cr. | 1,787 | 1,952/1,303 | 39.0 | 243 | 0.87 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,325 Cr. | 199 | 302/193 | 30.3 | 38.0 | 1.26 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 35,629 Cr. | 1,406 | 1,758/1,168 | 36.0 | 293 | 0.28 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,341 Cr. | 79.9 | 127/57.5 | 20.2 | 59.7 | 1.00 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 768 Cr. | 94.0 | 124/67.2 | 25.9 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,200 Cr. | 238 | 350/190 | | 106 | 0.08 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,924 Cr. | 237 | 457/217 | 290 | 96.9 | 0.59 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,340 Cr. | 1,575 | 2,496/1,243 | 30.6 | 397 | 0.44 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,540 Cr. | 349 | 498/285 | 65.2 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 14,117 Cr. | 582 | 621/412 | 27.6 | 164 | 0.26 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 55,252 Cr. | 1,957 | 2,286/1,275 | 22.0 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 43,285 Cr. | 2,554 | 3,516/1,921 | 45.4 | 101 | 1.64 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 27,431 Cr. | 1,666 | 2,131/1,200 | 23.7 | 610 | 1.08 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,726 Cr. | 413 | 528/359 | 29.8 | 149 | 1.21 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 21,167 Cr. | 1,552 | 1,910/1,097 | 50.9 | 227 | 0.47 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,06,833 Cr. | 1,280 | 1,406/1,020 | 18.5 | 432 | 0.62 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,800 Cr. | 242 | 322/178 | 25.4 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,21,073 Cr. | 1,499 | 1,673/1,310 | 22.2 | 408 | 0.87 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,483 Cr. | 1,908 | 2,641/1,551 | 24.6 | 416 | 0.31 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 282 Cr. | 95.8 | 203/93.5 | 20.2 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,693 Cr. | 160 | 191/105 | 15.4 | 107 | 0.31 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 53.7 Cr. | 33.0 | 63.1/32.5 | 18.8 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 52,402 Cr. | 392 | 425/291 | 110 | 200 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,564 Cr. | 1,549 | 2,050/1,430 | 34.6 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 117 Cr. | 73.0 | 132/70.0 | 17.1 | 49.2 | 1.64 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 338 Cr. | 147 | 205/67.8 | 32.0 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 22,645 Cr. | 9,077 | 10,691/6,301 | 98.0 | 320 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,017 Cr. | 697 | 843/544 | 35.6 | 118 | 0.66 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 159 Cr. | 76.4 | 137/75.0 | 8.47 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 66,025 Cr. | 5,521 | 5,868/4,492 | 28.1 | 1,116 | 0.82 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 16,677 Cr. | 848 | 1,124/725 | 26.3 | 271 | 1.30 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 425 Cr. | 747 | 1,412/736 | | 690 | 0.67 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 32,502 Cr. | 2,600 | 3,116/2,022 | 33.4 | 345 | 1.08 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,399 Cr. | 304 | 379/258 | 23.1 | 133 | 1.71 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,468 Cr. | 380 | 575/312 | 18.2 | 147 | 0.26 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,007.32 Cr | 1,144.50 | | 52.26 | 202.18 | 0.36% | 16.29% | 15.20% | 6.10 |